Study of Aripiprazole in Subjects With Alcoholism

Completed · Phase 4 · Has a placebo group

Conditions studied: Alcoholism

In brief

The purpose of this clinical research study is to learn whether subjects treated with aripiprazole are able to abstain from alcohol use for a greater number of days than subjects treated with placebo. The safety of using aripiprazole will also be studied.

Key facts

Study ID

NCT00082199

Run by

Otsuka Pharmaceutical Development & Commercialization, Inc.

People needed

400

Starts

2004-04-01

Expected to finish

2005-08-01

Last updated by the study team

2013-11-11

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with a diagnosis of alcohol dependence who want to stop using alcohol will be considered for the study.

Where it is running

• Local Institution — Farmington, Connecticut, United States
• Local Institution — New Haven, Connecticut, United States
• Local Institution — Indianapolis, Indiana, United States
• Local Institution — Boston, Massachusetts, United States
• Local Institution — New York, New York, United States
• Local Institution — Rochester, New York, United States
• Local Institution — Chapel Hill, North Carolina, United States
• Local Institution — Philadelphia, Pennsylvania, United States
• Local Institution — Providence, Rhode Island, United States
• Local Institution — Charleston, South Carolina, United States
• Local Institution — Dallas, Texas, United States
• Local Institution — Houston, Texas, United States
• Local Institution — Charlottesville, Virginia, United States
• Local Institution — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.